These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
502 related articles for article (PubMed ID: 17483343)
1. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343 [TBL] [Abstract][Full Text] [Related]
2. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]. Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336 [TBL] [Abstract][Full Text] [Related]
3. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995 [TBL] [Abstract][Full Text] [Related]
4. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs. Landis-Piwowar KR; Kuhn DJ; Wan SB; Chen D; Chan TH; Dou QP Int J Mol Med; 2005 Apr; 15(4):735-42. PubMed ID: 15754040 [TBL] [Abstract][Full Text] [Related]
6. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. Landis-Piwowar KR; Wan SB; Wiegand RA; Kuhn DJ; Chan TH; Dou QP J Cell Physiol; 2007 Oct; 213(1):252-60. PubMed ID: 17477351 [TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression. Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163 [TBL] [Abstract][Full Text] [Related]
9. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. Pan MH; Lin CC; Lin JK; Chen WJ J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658 [TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Hsuuw YD; Chan WH Ann N Y Acad Sci; 2007 Jan; 1095():428-40. PubMed ID: 17404055 [TBL] [Abstract][Full Text] [Related]
11. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556 [TBL] [Abstract][Full Text] [Related]
12. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799 [TBL] [Abstract][Full Text] [Related]
13. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065 [TBL] [Abstract][Full Text] [Related]
14. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG). Wang YC; Bachrach U Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181 [TBL] [Abstract][Full Text] [Related]
15. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. Yamauchi R; Sasaki K; Yoshida K Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223 [TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway. Wu PP; Kuo SC; Huang WW; Yang JS; Lai KC; Chen HJ; Lin KL; Chiu YJ; Huang LJ; Chung JG Anticancer Res; 2009 Apr; 29(4):1435-42. PubMed ID: 19414399 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression. Wang X; Hao MW; Dong K; Lin F; Ren JH; Zhang HZ Arch Pharm Res; 2009 Sep; 32(9):1263-9. PubMed ID: 19784583 [TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943 [TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. Rao SD; Pagidas K Anticancer Res; 2010 Jul; 30(7):2519-23. PubMed ID: 20682977 [TBL] [Abstract][Full Text] [Related]
20. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]